Alison Schram

27PUBLICATIONS
312CO-AUTHORS
Molecular targetsAutonomic nervous systemPredictive and prognostic markersProteins and peptidesLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Jul 01, 2026
Efficacy and Tolerability of Zenocutuzumab in Advanced NRG1 Fusion-Positive Cholangiocarcinoma: Results From the eNRGy Phase II Trial.

|Mar 04, 2026
Beamion PANTUMOR-1: rationale and design of a Phase II trial of zongertinib in HER2-overexpressed/amplified or HER2-mutant solid tumors.

Alison M Schram, John J Park, Antoine Italiano

|Dec 22, 2025
CRESTONE: A Phase II Study of the Efficacy and Safety of the HER3 Monoclonal Antibody, Seribantumab, in Solid Tumors With Neuregulin-1 (NRG1) Fusions.

Tejas Patil, Jessica J Lin, Parneet K Cheema

|Oct 07, 2025
The Bi-steric, mTORC1-Selective Inhibitor, RMC-5552, in Advanced Solid Tumors: A Phase 1 Trial.

Alison M Schram, Abdul Rafeh Naqash, Eric B Haura

|Sep 30, 2025
Tumor-Agnostic AKT Inhibition: Is It Time to AKT?

Ricardo Dahmer Tiecher, Alison M Schram

|Sep 16, 2025
Clinical Utility and Prognostic Implications of Circulating Cell-Free DNA in Biliary Tract Cancer.

Darren Cowzer, Madison Darmofal, Kenneth Seier

Pageof 5

Frequent Collaborators

9 joint publications

Alexander E Drilon

3 joint publications

Ahmet Zehir

3 joint publications

Misako Nagasaka

3 joint publications

Maurizio Scaltriti